BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21937448)

  • 1. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
    Dmitriev P; Petrov A; Ansseau E; Stankevicins L; Charron S; Kim E; Bos TJ; Robert T; Turki A; Coppée F; Belayew A; Lazar V; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
    J Biol Chem; 2011 Dec; 286(52):44620-31. PubMed ID: 21937448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: implications for the facio-scapulo-humeral dystrophy.
    Petrov A; Allinne J; Pirozhkova I; Laoudj D; Lipinski M; Vassetzky YS
    Genome Res; 2008 Jan; 18(1):39-45. PubMed ID: 18032730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
    Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
    Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.
    Thijssen PE; Balog J; Yao Z; Pham TP; Tawil R; Tapscott SJ; Van der Maarel SM
    Skelet Muscle; 2014; 4():19. PubMed ID: 25789155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors.
    Harafuji N; Schneiderat P; Walter MC; Chen YW
    Orphanet J Rare Dis; 2013 Apr; 8():55. PubMed ID: 23561550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy.
    Robin JD; Ludlow AT; Batten K; Gaillard MC; Stadler G; Magdinier F; Wright WE; Shay JW
    Genome Res; 2015 Dec; 25(12):1781-90. PubMed ID: 26359233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts.
    Petrov A; Pirozhkova I; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
    Proc Natl Acad Sci U S A; 2006 May; 103(18):6982-7. PubMed ID: 16632607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns.
    Cheli S; François S; Bodega B; Ferrari F; Tenedini E; Roncaglia E; Ferrari S; Ginelli E; Meneveri R
    PLoS One; 2011; 6(6):e20966. PubMed ID: 21695143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy.
    Banerji CRS; Panamarova M; Pruller J; Figeac N; Hebaishi H; Fidanis E; Saxena A; Contet J; Sacconi S; Severini S; Zammit PS
    Hum Mol Genet; 2019 Apr; 28(8):1244-1259. PubMed ID: 30462217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis.
    Knopp P; Krom YD; Banerji CR; Panamarova M; Moyle LA; den Hamer B; van der Maarel SM; Zammit PS
    J Cell Sci; 2016 Oct; 129(20):3816-3831. PubMed ID: 27744317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exchange of subtelomeric regions between chromosomes 4q and 10q reverts the FSHD genotype and phenotype.
    Ma Y; Schwager Karpukhina A; Dib C; Gautier C; Hermine O; Allemand E; Vassetzky YS
    Sci Adv; 2024 May; 10(18):eadl1922. PubMed ID: 38691604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of facioscapulohumeral muscular dystrophy.
    Tupler R; Gabellini D
    Cell Mol Life Sci; 2004 Mar; 61(5):557-566. PubMed ID: 15004695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Wohlgemuth M; Frants RR; Padberg GW; Morava E; van der Maarel SM
    Am J Hum Genet; 2004 Dec; 75(6):1124-30. PubMed ID: 15467981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through β-Catenin in Facioscapulohumeral Muscular Dystrophy.
    Ganassi M; Figeac N; Reynaud M; Ortuste Quiroga HP; Zammit PS
    Front Cell Dev Biol; 2022; 10():802573. PubMed ID: 36158201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.
    Himeda CL; Debarnot C; Homma S; Beermann ML; Miller JB; Jones PL; Jones TI
    Mol Cell Biol; 2014 Jun; 34(11):1942-55. PubMed ID: 24636994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the effects of FSHD candidate gene expression in vertebrate muscle development.
    Wuebbles RD; Long SW; Hanel ML; Jones PL
    Int J Clin Exp Pathol; 2010 Mar; 3(4):386-400. PubMed ID: 20490329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Van Overveld PG; Sandkuijl LA; Vrieling H; Padberg GW; Frants RR; van der Maarel SM
    Am J Hum Genet; 2004 Jul; 75(1):44-53. PubMed ID: 15154112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.
    Klooster R; Straasheijm K; Shah B; Sowden J; Frants R; Thornton C; Tawil R; van der Maarel S
    Eur J Hum Genet; 2009 Dec; 17(12):1615-24. PubMed ID: 19809486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophy.
    Pope BD; Tsumagari K; Battaglia D; Ryba T; Hiratani I; Ehrlich M; Gilbert DM
    PLoS One; 2011; 6(11):e27413. PubMed ID: 22096571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers.
    Arashiro P; Eisenberg I; Kho AT; Cerqueira AM; Canovas M; Silva HC; Pavanello RC; Verjovski-Almeida S; Kunkel LM; Zatz M
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6220-5. PubMed ID: 19339494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.